JPRN-UMIN000013048Completed未知
The study for efficacy of teneligliptin in non-alcoholic fatty liver disease (NAFLD) with type 2 diabetes mellitus - The study for efficacy of teneligliptin in non-alcoholic fatty liver disease (NAFLD) with type 2 diabetes mellitus
Sapporo Kosei General Hospital, Department of Hepatology0 sites100 target enrollmentStarted: February 3, 2014Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
- Enrollment
- 100
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 20years-old to 70years-old (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1) intake more than 20g/day of ethanol 2) HBsAg and/or HCV Ab positive 3) history of hepatic disease, such as autoimmune liver disease, hemochromatosis and Wilson's disease 4) history of diabetes ketosis and/or diabetic coma 5) during pregnancy
Investigators
Similar Trials
Completed
Phase 4
Clinical Study for the Effect of Teneligliptin on the Progressive Left Ventricular Diastolic Dysfunction in Patients with Type 2 Diabetes MellitusType 2 Diabetes MellitusJPRN-UMIN000014589TOPLEVEL study office936
Active, not recruiting
Phase 4
TOPLEVEL studyType 2 Diabetes MellitusJPRN-jRCTs051180136Kitakaze Masafumi936
Not yet recruiting
Phase 3
Study on Obesity management in non diabeticsCTRI/2020/02/023329Self financed
Completed
Not Applicable
Efficacy and safety of teneligliptin in patients with type 2 diabetes who responded insufficiently to dipeptidyl peptidase-4 (DPP-4) inhibitorsJPRN-UMIN000014298aka Kinen Clinic20
Completed
Not Applicable
The examination of the effects of Teneligliptin on blood glucose and albuminuria in type 2 diabetic patients with nephropathy, whose glycemic control is insufficient.Type 2 diabetic patients with nephropathyJPRN-UMIN000015922Kanazawa Medical University50